和康生 技 股東:個股董監事經理人持股明細
個股董監事經理人持股明細
Provide From Google
![和康生(1783) - 董監持股](https://i0.wp.com/api.multiavatar.com/%E5%92%8C%E5%BA%B7%E7%94%9F%281783%29+-+%E8%91%A3%E7%9B%A3%E6%8C%81%E8%82%A1_%E5%80%8B%E8%82%A1%E7%B8%BD%E8%A6%BD_%E5%8F%B0%E8%82%A1.png?apikey=viVnb6N20jclO8)
和康生(1783) - 董監持股
https://www.cnyes.com
鉅亨網提供你最完整的台股資訊。和康生董監持股,設質比例. ... 2023, 7, 大江生醫股份有限公司, 大股東本人, 0, 0, 0.00%. 2023, 7, 廖松淵, 獨立董事本人, 0, 0 ...
Provide From Google
![和康生砸5億增持大江](https://i0.wp.com/api.multiavatar.com/%E5%92%8C%E5%BA%B7%E7%94%9F%E7%A0%B85%E5%84%84%E5%A2%9E%E6%8C%81%E5%A4%A7%E6%B1%9F.png?apikey=viVnb6N20jclO8)
和康生砸5億增持大江
https://tw.yahoo.com
法人認為,和康生此次以交叉入股方式,以4.99億元買進大江股票,應該是承接大股東轉讓的持股。 和康生表示,在加入大江生技結盟創造綜效,全球業務 ...
Provide From Google
![和康生砸5億增持大江](https://i0.wp.com/api.multiavatar.com/%E5%92%8C%E5%BA%B7%E7%94%9F%E7%A0%B85%E5%84%84%E5%A2%9E%E6%8C%81%E5%A4%A7%E6%B1%9F-+%E5%B7%A5%E5%95%86%E6%99%82%E5%A0%B1.png?apikey=viVnb6N20jclO8)
和康生砸5億增持大江
https://ctee.com.tw
法人認為,和康生此次以交叉入股方式,以4.99億元買進大江股票,應該是承接大股東轉讓的持股。 和康生表示,在加入大江生技結盟創造綜效,全球業務 ...
Provide From Google
![股務資訊](https://i0.wp.com/api.multiavatar.com/%E8%82%A1%E5%8B%99%E8%B3%87%E8%A8%8A-+MBI%E5%92%8C%E5%BA%B7%E7%94%9F%E6%8A%80%7C%E7%8E%BB%E5%B0%BF%E9%85%B8%E9%87%9D%E5%8A%91%E8%88%87%E8%86%A0%E5%8E%9F%E8%9B%8B%E7%99%BD%E9%86%AB%E7%99%82%E5%99%A8%E6%9D%90%E9%A0%98%E5%B0%8E%E5%93%81%E7%89%8C.png?apikey=viVnb6N20jclO8)
股務資訊
https://mbi-bio.com
Dividend History. 欲了解MBI和康生技股價訊息,請上臺灣證券交易所網站查詢(代碼:1783)。 111年股東會開會通知 · 111年股東會議事手冊 · 111年4月22日前十大股東 ...
Provide From Google
![股東資訊](https://i0.wp.com/api.multiavatar.com/%E8%82%A1%E6%9D%B1%E8%B3%87%E8%A8%8A-+MBI%E5%92%8C%E5%BA%B7%E7%94%9F%E6%8A%80%7C%E7%8E%BB%E5%B0%BF%E9%85%B8%E9%87%9D%E5%8A%91%E8%88%87%E8%86%A0%E5%8E%9F%E8%9B%8B%E7%99%BD%E9%86%AB%E7%99%82%E5%99%A8%E6%9D%90%E9%A0%98%E5%B0%8E%E5%93%81%E7%89%8C.png?apikey=viVnb6N20jclO8)
股東資訊
https://mbi-bio.com
Provide From Google
![蟄伏高階生醫材料15年和康進軍世界蓄勢待發Part 1](https://i0.wp.com/api.multiavatar.com/%E8%9F%84%E4%BC%8F%E9%AB%98%E9%9A%8E%E7%94%9F%E9%86%AB%E6%9D%90%E6%96%9915%E5%B9%B4%E5%92%8C%E5%BA%B7%E9%80%B2%E8%BB%8D%E4%B8%96%E7%95%8C%E8%93%84%E5%8B%A2%E5%BE%85%E7%99%BCPart+1.png?apikey=viVnb6N20jclO8)
蟄伏高階生醫材料15年和康進軍世界蓄勢待發Part 1
https://www.gbimonthly.com
和康生技公司目前資本額為7.01億,主要股東為環宇集團(31%)、美國醫材公司NuVasive(6%)、兆豐金控(5%)、第一金控(2%)及董監事及經營團隊(17%)。 總經理張立言及資深副總 ...